BioInvent and Transgene and report positive BT-001 data
Tumour treatment among all phase 1a cohorts in were concluded with no safety concerns
Read More
Tag: transgene
Transgene receives approval to begin oncolytic virus trial
Study will evaluate the intravenous administration of company’s multi-armed immunotherapy
Read More
AZ, Transgene to collaborate on immunotherapies
The French biotech company will help AstraZeneca to co-develop five armed oncolytic vaccinia virus candidates.
Read More
BMS, Transgene to test new lung cancer combination therapy
Bristol-Myers Squibb and Transgene are to test a potential new therapy for advanced non-squamous non-small cell lung cancer (NSCLC) combining a PD-1 immune checkpoint inhibitor, vaccine and chemotherapy.
Read More
Transgene links with Merck, Pfizer for head and neck cancer trial
Transgene has entered into collaboration agreement with Merck KGaA and Pfizer under which it will sponsor an early-stage study testing a potential new combination treatment for head and neck cancer.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
